新华医疗
(600587)
| 流通市值：76.74亿 | | | 总市值：76.74亿 |
| 流通股本：6.07亿 | | | 总股本：6.07亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 7,355,283,881.02 | 5,160,672,255.84 | 2,253,927,001.42 | 9,736,089,608.71 |
| 营业总成本 | 6,854,434,875.64 | 4,729,810,762.1 | 2,091,993,896.87 | 9,132,053,228.23 |
| 其他经营收益 | | | | |
| 营业利润 | 434,498,643.99 | 356,547,906.19 | 147,241,844.37 | 590,866,815.68 |
| 利润总额 | 438,353,162.75 | 359,461,057.56 | 149,126,647.99 | 591,120,527.05 |
| 净利润 | 360,411,070.99 | 289,313,008.85 | 124,671,604.99 | 528,134,579.86 |
| 每股收益 | | | | |
| 其他综合收益 | -10,231,585.4 | -10,231,585.4 | - | -1,628,422.22 |
| 综合收益总额 | 350,179,485.59 | 279,081,423.45 | 124,671,604.99 | 526,506,157.64 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 9,072,899,958.06 | 9,107,554,286.23 | 8,819,359,336.04 | 8,893,586,828.82 |
| 非流动资产: | | | | |
| 非流动资产合计 | 5,808,940,788.53 | 5,836,640,344.03 | 5,888,928,585.28 | 5,925,983,426.35 |
| 资产总计 | 14,881,840,746.59 | 14,944,194,630.26 | 14,708,287,921.32 | 14,819,570,255.17 |
| 流动负债: | | | | |
| 流动负债合计 | 6,249,935,889.01 | 6,396,159,116.89 | 6,245,411,392.26 | 6,547,485,840.16 |
| 非流动负债: | | | | |
| 非流动负债合计 | 375,110,277.56 | 360,764,820.39 | 362,914,460.32 | 314,888,506.94 |
| 负债合计 | 6,625,046,166.57 | 6,756,923,937.28 | 6,608,325,852.58 | 6,862,374,347.1 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 7,943,863,958.34 | 7,865,019,288.24 | 7,779,142,639.06 | 7,634,042,504.4 |
| 股东权益合计 | 8,256,794,580.02 | 8,187,270,692.98 | 8,099,962,068.74 | 7,957,195,908.07 |
| 负债和股东权益合计 | 14,881,840,746.59 | 14,944,194,630.26 | 14,708,287,921.32 | 14,819,570,255.17 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 7,157,632,197.23 | 4,808,526,735.24 | 2,246,483,972.21 | 9,488,712,865.55 |
| 经营活动现金流出小计 | 6,930,687,882.24 | 4,543,795,102.52 | 2,178,821,413.66 | 8,788,075,945.15 |
| 经营活动产生的现金流量净额 | 226,944,314.99 | 264,731,632.72 | 67,662,558.55 | 700,636,920.4 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 325,875,775.86 | 9,795,874.12 | 2,329,354.02 | 222,641,058.45 |
| 投资活动现金流出小计 | 792,681,709.73 | 753,460,031.62 | 726,830,367.55 | 405,494,135.95 |
| 投资活动产生的现金流量净额 | -466,805,933.87 | -743,664,157.5 | -724,501,013.53 | -182,853,077.5 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 701,694,625.15 | 423,773,740.22 | 301,000,000 | 1,217,539,962.71 |
| 筹资活动现金流出小计 | 917,191,285.53 | 636,475,349.93 | 342,073,991.71 | 1,537,858,450.93 |
| 筹资活动产生的现金流量净额 | -215,496,660.38 | -212,701,609.71 | -41,073,991.71 | -320,318,488.22 |
| 汇率变动对现金及现金等价物的影响 | -7,186,122.31 | -5,647,558.24 | -3,483,751.12 | -371,650.43 |
| 现金及现金等价物净增加额 | -462,544,401.57 | -697,281,692.73 | -701,396,197.81 | 197,093,704.25 |
| 期末现金及现金等价物余额 | 2,504,312,243.7 | 2,269,574,952.54 | 2,265,460,447.46 | 2,966,856,645.27 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -697,281,692.73 | - | 197,093,704.25 |
最新报告期：2026-09-20| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华创证券 | 郑辰,张良龙,李婵娟 | 0.91 | 1.05 | 1.16 | 2026-09-20 |
| 华源证券 | 刘闯,林海霖 | 0.95 | 1.03 | 1.11 | 2026-09-15 |